Phospholamban anticorps (pSer16, pThr17)
Aperçu rapide pour Phospholamban anticorps (pSer16, pThr17) (ABIN7269330)
Antigène
Voir toutes Phospholamban (PLN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pSer16, pThr17
-
Fonction
- Phospho-PLN-S16/T17 Rabbit pAb
-
Réactivité croisée
- Humain, Souris, Rat
-
Attributs du produit
- Phosphorylated Antibodies
-
Purification
- Affinity purification
-
Immunogène
- A synthetic phosphorylated peptide around of human Phospho-PLN-S16/T17.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- Phospholamban (PLN)
-
Autre désignation
- PLN
-
Sujet
- The protein encoded by this gene is found as a pentamer and is a major substrate for the cAMP-dependent protein kinase in cardiac muscle. The encoded protein is an inhibitor of cardiac muscle sarcoplasmic reticulum Ca(2+)-ATPase in the unphosphorylated state, but inhibition is relieved upon phosphorylation of the protein. The subsequent activation of the Ca(2+) pump leads to enhanced muscle relaxation rates, thereby contributing to the inotropic response elicited in heart by beta-agonists. The encoded protein is a key regulator of cardiac diastolic function. Mutations in this gene are a cause of inherited human dilated cardiomyopathy with refractory congestive heart failure, and also familial hypertrophic cardiomyopathy.,CMD1P,CMH18,PLB,PLN,Cancer,Signal Transduction,Endocrine & Metabolism,Neuroscience,Calcium Signaling,Cardiovascular,Heart,Contractility,PLN
-
Poids moléculaire
- 6kDa
-
ID gène
- 5350
-
UniProt
- P26678
-
Pathways
- Negative Regulation of Transporter Activity
Antigène
-